• Norovirus Exploits NINJ1 for Selective NS1 Secretion and Hos

  2026-07-23

  Song et al. reveal that murine norovirus leverages the host membrane protein NINJ1 to selectively secrete its NS1 protein, distinguishing this from the bulk release of cellular DAMPs during cell death. This work uncovers a novel, selective secretion mechanism, with broad implications for understanding viral immune evasion and the regulation of programmed cell death.

• Plasma-Activated Media Inhibits EMT and Intestinal Fibrosis

  2026-07-23

  This study demonstrates that plasma-activated media (PAM) can effectively inhibit epithelial-mesenchymal transition (EMT) and ameliorate intestinal fibrosis in preclinical models by targeting the PPARγ/TGF-β1/SMAD3 pathway. The findings provide mechanistic insight into PAM's anti-fibrotic action and offer novel directions for therapeutic intervention in inflammatory bowel disease-associated fibrosis.

• DFCP1 Modulates Starvation-Induced ATGL Activity in Lipid Dr

  2026-07-22

  This study uncovers Double FYVE Domain Containing Protein 1 (DFCP1) as a direct, nutrient-sensitive regulator of ATGL-mediated lipid droplet (LD) lipolysis during cellular starvation. The findings clarify DFCP1’s mechanistic role in LD metabolism, with important implications for understanding metabolic disease and optimizing protein stability protocols in lipid research.

• Ciprofloxacin Hydrochloride: Advanced Workflows & Single-Cel

  2026-07-22

  Ciprofloxacin hydrochloride stands apart as a fluoroquinolone antibiotic, offering not only robust antibacterial activity but also unique immunomodulatory and research applications. This article delivers actionable protocols, troubleshooting insight, and translates recent single-cell research findings into practical guidance for experimental optimization.

• Mifepristone (RU486): Molecular Pathways and Assay Innovatio

  2026-07-21

  Explore the multifaceted roles of Mifepristone (RU486) in cancer and reproductive research. This article uncovers its unique molecular mechanisms and provides advanced assay guidance for scientific investigators.

• Phosbind Acrylamide: Precision Phosphate-Binding for SDS-PAG

  2026-07-21

  Phosbind Acrylamide enables direct, antibody-free detection of phosphorylated proteins by leveraging specific phosphate-binding in SDS-PAGE workflows. Its robust separation capabilities empower dynamic phosphorylation analyses, streamlining both basic research and advanced kinase signaling studies.

• Weight Loss Restores Intestinal Stretch Signals in Metabolic

  2026-07-20

  This article examines a recent study that uncovers how weight loss, via diet or surgery, reverses obesity-induced impairments in gastrointestinal stretch-mediated regulation of feeding and glucose metabolism. The findings challenge the primacy of classical incretin signaling, highlighting alternative mechanosensory pathways with significant implications for metabolic disease research.

• ECL Chemiluminescent Substrate Detection Kit (Hypersensitive

  2026-07-20

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) addresses challenges in immunoblotting detection of low-abundance proteins, enabling reliable visualization at low picogram levels. This kit is intended for research use in Western blot and related immunodetection workflows, but is not suitable for diagnostic or clinical applications.

• AT13387: Advancing Hsp90 Inhibition in Translational Oncolog

  2026-07-19

  This article delivers a thought-leadership perspective on leveraging AT13387, a next-generation Hsp90 inhibitor, for translational cancer biology research. It integrates mechanistic insights into Hsp90 chaperone inhibition and apoptosis induction, contextualizes competitive challenges, and offers strategic protocol guidance, while drawing cross-domain lessons from recent advances in regulated cell death and protein secretion.

• Bradykinin (BA5201): Protocol Guidance for Vasodilator Resea

  2026-07-18

  Bradykinin (SKU BA5201) is a research-grade endothelium-dependent vasodilator designed for acute-phase studies in vascular permeability, smooth muscle contraction, and pain or inflammation signaling. It is not suitable for diagnostic or medical use, and care should be taken to follow product-specific storage and handling protocols to ensure reproducibility.

• tRF16–ALKBH5 Axis Drives Osteoarthritis via m6A-Mediated NF-

  2026-07-17

  This study uncovers how tRF16, a tRNA-derived fragment, promotes osteoarthritis progression by destabilizing NFKBIA mRNA through downregulation of the m6A demethylase ALKBH5. The research establishes a mechanistic link between RNA modifications, inflammatory signaling, and cartilage degeneration, offering new directions for biomarker discovery and targeted interventions.

• MHY1485: mTOR Activator Workflows for Autophagy and Follicle

  2026-07-17

  MHY1485, an advanced mTOR activator from APExBIO, enables precise modulation of autophagy and cell proliferation across cancer and reproductive models. This article details experimental workflows, troubleshooting strategies, and actionable insights grounded in the latest research—empowering scientists to optimize their mTOR signaling pathway studies.

• Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Variant Host Ra

  2026-07-16

  Shukla et al. introduce a high-throughput barcoded pseudovirus assay to systematically map how SARS-CoV-2 spike variants interact with diverse ACE2 receptor sequences. This innovation uncovers that although human ACE2 compatibility changes subtly, viral evolution dramatically expands cross-species receptor usage, offering new insights into host range determinants and zoonotic risk.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Oxidati

  2026-07-16

  GKT137831 empowers researchers to dissect oxidative stress-driven pathologies with nanomolar precision, enabling reproducible vascular, liver, and diabetes-related models. This dual NADPH oxidase Nox1/Nox4 inhibitor unlocks advanced protocol control and troubleshooting for complex in vitro and in vivo workflows.

• Cisplatin in Cancer Research: Workflows, Innovations & Tips

  2026-07-15

  Cisplatin (CDDP) remains a cornerstone in translational cancer research, offering unparalleled utility for apoptosis assays and tumor xenograft studies. This guide distills cutting-edge experimental workflows, troubleshooting strategies, and insights from recent resistance research, empowering scientists to maximize the reproducibility and impact of their Cisplatin-based protocols.

11428 records 1/762 page Next 12345 下5页 Last page